Upton, MA, United States of America

Leonard Estis


Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 170(Granted Patents)


Company Filing History:


Years Active: 1991-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Leonard Estis: Innovator in Liposomal Adjuvants

Introduction

Leonard Estis is a notable inventor based in Upton, MA (US). He has made significant contributions to the field of immunology through his innovative work on liposomal adjuvants. With a total of 3 patents, Estis has focused on enhancing immune responses using advanced liposomal formulations.

Latest Patents

Estis's latest patents include groundbreaking technologies aimed at improving immunization methods. One of his patents describes a high integrity liposome that comprises at least one stable lipid and at least one peptide-like therapeutic agent. This formulation is designed for parenteral administration to animals, including humans. Another patent focuses on immunizing dosage forms that combine a liposome with an immunogen, ensuring both components are present in an effective immunization dose. Additionally, he has developed a dosage form that includes dimyristoylphosphatidylcholine (DMPC)/cholesterol liposomes, which may be used in conjunction with an aluminum hydroxide gel to produce a robust immune response.

Career Highlights

Estis has dedicated his career to advancing the science of immunology through innovative liposomal technologies. His work has been instrumental in developing new methods for vaccine delivery and immune response enhancement.

Collaborations

Throughout his career, Estis has collaborated with esteemed colleagues such as Mircea C Popescu and Alan L Weiner. These partnerships have contributed to the success and impact of his research in the field.

Conclusion

Leonard Estis stands out as a prominent inventor in the realm of liposomal adjuvants, with a focus on improving immunization techniques. His contributions continue to influence the field of immunology and vaccine development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…